Clin Osteol 2004; 9(3): 75-77
Androgenous state in patients presenting with osteoporosisInformations
Androgen deficiency may cause secondary osteoporosis in men. The purpose of our study was to determine, as part of differential diagnosis, the con centrations of total testosterone, LH and estradiol in men presenting with newly diagnosed idiopathic osteoporosis and osteopenia. In a group of 57 men, mean age 54 years, presenting with idiopathic osteoporosis and densitometrically established osteopenia we determined serum concentra tions of total testosterone, LH and estradiol. We did not find the upper limit of normal serum testosterone levels in any of the patients - actually none of the patients presented even 75 % of the physiological range. In 89 % of the patients testosterone was lower than the mean of the physiological range and in 4 patients the testoserone values were below the lower limit of normal values. LH values were in 91 % of the patients within the normal range. 1 patient had a somewhat lower LH value, while in 4 of them this value was higher than normal values. 90 % of the patients had normal estradiol va lues, 3 had somewhat higher values. We could not confirm clinical manifestations of hypogonadism in our set of patients. Our results indicate that the determination of total testosterone, which in contrast to its free fraction does not express the appropriate androgenous condition, is not necessarily a contribution to the routine diagnosis of male osteoporosis. Lower total testosterone values, which remain within the normal range, indicate a possible role of androgens in the development of osteoporosis in the male population.
Keywords: bone mineral density, men, testosterone.
Published: December 11, 2004 Show citation
References
- Orwoll E. Osteoporosis in men. The effects of gender on skeletal health. Acade mic Press, London 1999:582.
- Masaryk P. Epidemiológia osteoporózy na Slovensku. Abstrakt z Pracovnej kon ferencie Slovenskej reumatologickej spoločnosti "Osteoporóza, diagnostika a lieč ba. Biomin H - uplatnenie v klinickej praxi", Piešťany 16. 3. 1993:5-12.
- P^yer J, Killinger Z. Hormóny a kosť. Osteol bul 2001;6:113-116.
- P^yer J, et al. Význam androgénov a rastového hormónu pri vzniku osteoporózy. Osteol Bul 1999;4:40-42.
- Sotorník R. Osteoporosis in men, Diabetologie, metabolismus, endokrinologie, Výživa 2000;3:264-272.
- Štepán J, et al. Castrated men exhibit bone loss: effects of calcitonin treatment on biochemical indicesof bone remodeling. J Clin Endocrinol Metab 1989; 69:523-527.
Go to original source... - Gilberg P, et al. Bone mineral density in femoral neck is positively correlated or circulating insulin-like growth factor (IGF-I) and IGF-binding protein (IGFBP-3) in swedish men. Calcif Tissue Int 2002;70:22-29.
Go to original source... - Center JR, et al. Hormonal and biochemical parameters and osteoporotic fractures in elderly men. J Bone Miner Res 2000;15:1405-1411.
Go to original source... - Huber DM, et al. Androgens suppress osteoclast formation induced by RANKL and macrophage - colony stimulating factors, Endocrinology 2001;142:3800-8.
Go to original source... - Hofbauer LC, Khosla S. Androgen effects on bone metabolism:recent progress and controversies. Eur J Endocrin 1999;140: 271-286.
Go to original source... - Langard E, et al. Osteoporosis in men: a potential role for the sex hormone bin ding globulin, Bone 2001;29:90-95.
Go to original source...

